• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Hollister

    Hollister
    hollister

  • Michael Lee, Australia

    Michael Lee, Australia

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Zabun Nassar, England

    Zabun Nassar, England

  • Daniel Hare, USA

    Daniel Hare, USA

  • Greg Heydet, USA

    Greg Heydet, USA

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Hans Dieter Olszewski, Germany

    Hans Dieter Olszewski, Germany

  • Imelda Arenas, Colombia

    Imelda Arenas, Colombia

  • Natalya Rybakova, Russia

    Natalya Rybakova, Russia

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Mahmood Anwar, UK

    Mahmood Anwar, UK

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Dan Doctoroff, USA

    Dan Doctoroff, USA

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • David Bishop, UK

    David Bishop, UK

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Nicholas (Nic) Bowman, South Africa

    Nicholas (Nic) Bowman, South Africa

  • Anderson Custodio Pinto, Brazil

    Anderson Custodio Pinto, Brazil

  • Chris McCauley, Canada

    Chris McCauley, Canada

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Art Eggert, USA

    Art Eggert, USA

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Glen Elison, USA

    Glen Elison, USA

  • Roxana Canova, Argentina

    Roxana Canova, Argentina

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Verónica Isabel Castro Molina, Argentina

    Verónica Isabel Castro Molina, Argentina

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login